These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8063331)
1. Effective control of cisplatin induced emesis by combination drug regimen. Misra R; Agarwal N Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331 [TBL] [Abstract][Full Text] [Related]
2. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis. Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977 [TBL] [Abstract][Full Text] [Related]
3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
4. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039 [TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research. Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965 [TBL] [Abstract][Full Text] [Related]
6. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents. Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120 [TBL] [Abstract][Full Text] [Related]
7. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis. Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119 [TBL] [Abstract][Full Text] [Related]
8. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905 [TBL] [Abstract][Full Text] [Related]
9. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting. Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A J BUON; 2007; 12(2):245-52. PubMed ID: 17600880 [TBL] [Abstract][Full Text] [Related]
10. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research. Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702 [TBL] [Abstract][Full Text] [Related]
11. [The effect of metoclopramide, dexamethasone and antihistamine in the prevention of PAC chemotherapy-induced emesis]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):153-9. PubMed ID: 3361170 [TBL] [Abstract][Full Text] [Related]
12. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial]. Fujii M; Kiura K; Kamei H; Okabe K; Toki H Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting]. Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy. Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193 [TBL] [Abstract][Full Text] [Related]
16. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin. Stephens SH; Silvey VL; Wheeler RH Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711 [TBL] [Abstract][Full Text] [Related]
19. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536 [TBL] [Abstract][Full Text] [Related]
20. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]